Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Topical cantharidin-podophylotoxin-salicylic acid (CPS) treatment of recalcitrant plantar warts

Discussion in 'General Issues and Discussion Forum' started by NewsBot, Apr 14, 2016.

Tags:
  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Safety and effectiveness of cantharidin-podophylotoxin-salicylic acid in the treatment of recalcitrant plantar warts.
    Lopez Lopez et al
    Dermatol Ther. 2016 Apr 12
     
  2. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Cantharidin (1%), podophyllin (5%), and salicylic acid (30%) formulation in recalcitrant plantar warts: Analysis of 48 patients
    Jéssica Amo-Navarrete, Sara García-Oreja, Diego León-Herce, David Navarro-Pérez, José Luís Lázaro-Martínez, Francisco Javier Álvaro-Afonso
    18 September 2024 https://doi.org/10.1002/jmv.29925
     
Loading...

Share This Page